Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Verona Pharma Plc ADR’s current trading price is 2.58% away from its 52-week high, while its distance from the 52-week low is 602.28%. The stock’s price range over this period has fluctuated between $11.39 and $77.98. The company, operating within the financial sector, had a trading volume of approximately 1.26 million for the day, which was noticeably lower than the average daily share volume of 1.36 million over the last 3 months.
Verona Pharma Plc ADR experienced a rather steady stock market performance. The highest value in the past year was recorded at $77.98 on 05/30/25 and the lowest value was $11.39 on 05/30/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Verona Pharma Plc ADR (VRNA) has experienced a quarterly rise of 14.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.81B and boasts a workforce of 209 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 62.72, with a change in price of +33.58. Similarly, Verona Pharma Plc ADR recorded 1,439,061 in trading volume during the last 100 days, posting a change of +72.08%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for VRNA stands at 1.08. Similarly, the long-term debt-to-equity ratio is also 1.07.
VRNA Stock Stochastic Average
Today, Verona Pharma Plc ADR’s raw stochastic average for the past 50 days stands at 97.54%, indicating a rise from the raw stochastic average of the last 20 days, which was 95.95%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 91.64% and 90.68% respectively.
VRNA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 72.24% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 101.59%. Over the past 30 days, the price of VRNA has fallen by 10.99%. And in the last five days, it has surged by 10.04%.
